Penrhos Bio joins with Pro3dure™ in a milestone licence deal that will bring the Remora™ technology into the dental space in 3D printed materials
Through our licence partner in the dental field, (Jernberg Biotechnology), Penrhos Bio has formed a new and exciting partnership with Pro3dure Medical. Pro3dure are world leading in 3D printing technology for medical devices, including in the dental space. https://www.pro3dure.com.
Working closely with Penrhos Bio, and leveraging the R&D expertise of our technical team in Unilever, Pro3dure are developing and launching their new product, MIS, which incorporates our Remora™️ technology.
Quote from Richard Hammond CEO of Penrhos Bio:
We are thrilled to be working with our colleagues at Pro3dure Medical to combine the power of Remora™️ technology with their world leading expertise in material development. The result is a completely novel way of inhibiting the formation of harmful multispecies biofilms in their MIS products. Remora™️ is inspired by the natural biology certain seaweeds have developed which enables them to block communication between microorganisms. The result is a surface that remains clean and free of biofilms. Backed by Unilever, we have proven efficacy in a wide range of applications, and we are really excited to bring this benefit into dental markets through the innovation of Pro3dure, an ideal partnership.
